ANIS RASHID: Open Payments
NPI 1891891925 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$155 in 7 payments from 6 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $155
Food & beverage: $155
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $39 |
| Neurocrine BioSciences, Inc. | 1 | $29 |
| Corium, LLC | 1 | $29 |
| Otsuka America Pharmaceutical, Inc. | 1 | $23 |
| Axsome Therapeutics, Inc. | 1 | $20 |
| ABBVIE INC. | 1 | $15 |
Products named: CAPLYTA, INGREZZA, Azstarys, REXULTI, Auvelity, VRAYLAR.
Industry payments across TX — which companies pay providers there.
